These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 8481216)
1. Adverse effects of antimalarials. An update. Luzzi GA; Peto TE Drug Saf; 1993 Apr; 8(4):295-311. PubMed ID: 8481216 [TBL] [Abstract][Full Text] [Related]
2. Antimalarial drug toxicity: a review. AlKadi HO Chemotherapy; 2007; 53(6):385-91. PubMed ID: 17934257 [TBL] [Abstract][Full Text] [Related]
3. Antimalarial drug toxicity: a review. Taylor WR; White NJ Drug Saf; 2004; 27(1):25-61. PubMed ID: 14720085 [TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries. Mengesha T; Makonnen E East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517 [TBL] [Abstract][Full Text] [Related]
8. The safety of antimalarial drugs in pregnancy. Phillips-Howard PA; Wood D Drug Saf; 1996 Mar; 14(3):131-45. PubMed ID: 8934576 [TBL] [Abstract][Full Text] [Related]
9. Artemisinin derivatives and malaria: useful, in combination with other antimalarials. Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494 [TBL] [Abstract][Full Text] [Related]
10. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment. Peters PJ; Thigpen MC; Parise ME; Newman RD Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875 [TBL] [Abstract][Full Text] [Related]
11. Malaria prevention in travellers from the United Kingdom. Report of meetings convened by the Ross Institute. Br Med J (Clin Res Ed); 1981 Jul; 283(6285):214-8. PubMed ID: 6789972 [TBL] [Abstract][Full Text] [Related]
12. Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand. Boudreau EF; Pang LW; Chaikummao S; Witayarut C Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):183-9. PubMed ID: 1948277 [TBL] [Abstract][Full Text] [Related]
13. Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain. Phillips-Howard PA; West LJ J R Soc Med; 1990 Feb; 83(2):82-5. PubMed ID: 2138674 [TBL] [Abstract][Full Text] [Related]
15. [The proper use of antimalarial drugs currently available]. Bourgeade A; Delmont J Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):493-6. PubMed ID: 10078393 [TBL] [Abstract][Full Text] [Related]
16. [Adverse drug reactions (ADRs) to antimalarial drugs. Analysis of spontaneous report from the French pharmacovigilance database (1996-2000)]. Angles A; Bagheri H; Montastruc JL; Magnaval JF; Presse Med; 2003 Jan; 32(3):106-13. PubMed ID: 12610379 [TBL] [Abstract][Full Text] [Related]
17. Recent acquisitions on chemotherapy and chemoprophylaxis of malaria. Onori E; Majori G Ann Ist Super Sanita; 1989; 25(4):659-73. PubMed ID: 2698608 [TBL] [Abstract][Full Text] [Related]
18. Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment. Menard D; Djalle D; Manirakiza A; Yapou F; Siadoua V; Sana S; Matsika-Claquin MD; Nestor M; Talarmin A Am J Trop Med Hyg; 2005 Aug; 73(2):239-43. PubMed ID: 16103582 [TBL] [Abstract][Full Text] [Related]
19. [Malaria prophylaxis: what is safe?]. Holzer RB Ther Umsch; 1990 Oct; 47(10):795-808. PubMed ID: 2260020 [TBL] [Abstract][Full Text] [Related]